PTX 3.70% 3.9¢ prescient therapeutics limited

Ann: December 2017 Appendix 4C - Quarterly, page-10

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Always a pleasure to read your posts maxter.
    Still cat and mouse games here..., that is, nothing that 1mil or so shares to see pre-consolidation levels.
    Not sure if the ‘off screen selling has subsided yet, hoping for a few more at sub 6 if you are reading this.
    Seriously though, have been waiting in vain re phase 1 full analysis. Should give us holders a more comprehensive feel of data (Ann Q1).
    Have had some luck with a couple of bios recently (vla and srx- both takeovers).
    Seems bios are back in big pharma’s eye.
    Hoping for a more linguistically appealing report than the top end statement (breast cancer trial) released last time by management.
    Luck to holders.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.002(3.70%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $31.53K 794.9K

Buyers (Bids)

No. Vol. Price($)
8 456872 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 66952 1
View Market Depth
Last trade - 15.43pm 24/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.